Molecular Diagnostics
Novel Variant of Phosphorylated Tau Helps Fine Tune Early Diagnosis of Alzheimer’s Disease
A team of neurodegenerative disease researchers has identified an additional phosphorylated tau protein variant that augments the toolbox of biomarkers for early diagnosis of Alzheimer’s disease. More...10 Nov 2022
POC Molecular Diagnostics Analyzer for Infectious Diseases Provides On-The-Spot Results
A new POC molecular diagnostics analysis system based on Loop-Mediated Isothermal Amplification (LAMP) provides on-the-spot results and empowers physicians for early infectious disease diagnostics, thanks to its agility, speed and flexibility. More...10 Nov 2022
Rapid Test for G6PD Deficiency Runs on Toaster-Sized Instrument and Delivers Results in 15 Minutes at POC
Baebies (Durham, NC, USA) has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its rapid, point-of-care test for G6PD deficiency. The test is run on the FINDER platform, which features a toaster-sized instrument and a disposable cartridge. Using a 50 µL blood sample (one drop of blood), FINDER delivers results in approximately 15 minutes after sample introduction More...10 Nov 2022
New Urine Test Could Detect Childhood Kidney Disease Earlier than Current Assays
Researchers have developed a new technique analyzing urine extracellular vesicles (uEVs) - cell-derived nanoscale spherical structures involved in multiple biological functions - in urine samples that identifies changes in the kidneys earlier than conventional methods and can also predict renal function decline. More...10 Nov 2022
New
Gold Member
Collection and Transport System
PurSafe Plus®
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
In Other News
Ultra-Fast Real-Time PCR Platform Could Revolutionize POC Molecular Diagnostics
Personalizing Whole Genome Sequencing Doubles Diagnosis of Rare Diseases
New Blood Test to Help Physicians Prevent Major Cardiovascular Events in Women with Lupus
Accurate Genetic Assay Identifies Human Neutrophil Antigen 2 Deficiency
Levels of the MicroRNA MiR-145 Predict Likelihood of Breast Cancer Recurrence
Nose Swabs May Distinguish Babies with RSV Needing Longer Intensive Care
New Immunoassay Specifically Measures Heart Attack-linked Blood Troponin Levels
A Procedure for Early Diagnosis of Pancreatic Cancer
Pathogen Analyzer Combines Advantages of Antigen and PCR Testing
Fast, Open and Digitalized PCR Platform Produces Results in 15 Minutes
Novel Phage- and CRISPR-Based Approaches to Enable Diagnosis of Sepsis in Blood Samples
New Test Identifies Women Less Likely to Respond to Standard Breast Cancer Treatment
New Test Detects Antibodies Responsible for Thromboses and Miscarriages
New Molecular Diagnostic System to Expand Access to PCR Testing in the U.S.
Novel Nanopore-Based Technology Rapidly and Precisely Detects Pathogens for Cancer Patients
Blood Test Accurately Diagnoses Early-Stage Osteoarthritis
Next-Gen Whole Blood DNA Collection and Extraction Kit to Introduce Cutting-Edge Capabilities
Liquid Biopsies Can Identify Cancer Patients at Higher Risk of Developing Additional Blood Cancers
World’s First Portable, High Yield Sequencer Provides Comprehensive DNA Analysis for Anyone, Anywhere
Diagnostic Tool Applies Machine Learning to Identify and Predict Sepsis Cases
Hematological Neoplasm Cytogenetics Profiled With Optical Genome Mapping
Super-Enhancer Induces Oncogenic Driver in Colorectal Carcinoma
Simple Blood Test Could Offer Smarter Treatment for Children’s Cancer
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.